Treatment with sivelestat sodium of acute respiratory distress syndrome induced by chemical pneumonitis: A report of three cases

Exp Ther Med. 2023 Aug 22;26(4):476. doi: 10.3892/etm.2023.12175. eCollection 2023 Oct.

Abstract

Inhalation of acid fumes and aspiration of liquid substances or gastric contents may not initiate dyspnea within several hours after exposure but may result in delayed onset of alveolar edema. The present report presents three cases of inhalation or aspiration of chemical substances that resulted in acute respiratory distress syndrome (ARDS). Due to different underlying reasons, three patients developed ARDS resulting from chemical pneumonitis and pulmonary infection. From patients with dyspnea, dry rales could be heard in both lungs, with <92% percutaneous oxygen saturation at room air. All patients were treated using a high-flow nasal cannula and sivelestat sodium. Oxygenation gradually improved and the patients were discharged without adverse events. These cases suggest that early treatment with sivelestat sodium may improve the clinical outcomes of patients with ARDS.

Keywords: acute respiratory distress syndrome; aspiration; chemical pneumonitis; pulmonary infection; sivelestat sodium.

Publication types

  • Case Reports

Grants and funding

Funding: This work was supported by the Scientific Research Project of Hubei Provincial Health and Family Planning Commission (grant no. WJ2019M123).